Use of antibody-drug conjugate for treating diseases

TW202641590APending Publication Date: 2026-10-16SHANGHAI HANSOH BIOMEDICAL CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114151240
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-26
Filing Date
2025-12-24
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080812_001
    Figure TWG2TA001080812_001
  • Figure TWG2TA001080812_002
    Figure TWG2TA001080812_002
Patent Text Reader

Abstract

The present invention relates to use of antibody-drug conjugate for treating diseases. Specifically, the invention provides for treating head and neck cancer using antibody-drug conjugates, pharmaceutically acceptable salts, stereoisomers, or metabolite thereof, or solvates of the aforementioned items, and the use of the antibody-drug conjugate in the preparation of a medicament for the prevention and / or treatment of head and neck cancer. The method and the use exhibit superior disease control and objective response rates, and can meet medical needs.
Need to check novelty before this filing date? Find Prior Art